Join DS2 at Finance & Accounting for Bioscience 2026
DS2 will be at Finance & Accounting for Bioscience at the Sheraton Boston on September 24 and 25, in the sessions across both days and meeting customers and partners around them. Put a time in with us.
Let's Connect in Boston
This is the room where biotech CFOs, chief accounting officers, controllers and FP&A leads work through what their programmes actually cost. Finance leaders from Biogen, Vertex, Alnylam, Moderna, Roivant, Akebia, BridgeBio and a long list of pre-commercial companies are on the published faculty, alongside the SEC and FASB. Clinical logistics is a real line in those budgets, and we provide industry-leading solutions across the entire connected sample supply chain. Kit build and fulfillment, courier and cold chain, biostorage and the integration behind them all carry cost that is easier to forecast when one partner runs the whole path. We're looking forward to talking about how that consolidates, what it does to trial accruals, and what it looks like as a programme moves toward commercialization.
We often find during these events that the diary fills up quickly. Use the form and we'll block a time for you to meet our team while availability lasts.
Why Attend Finance & Accounting for Bioscience 2026?
Informa Connect describes the event as the "Pharma/Biotech Industry's Essential Forum for Advancing Financial and Commercial Success of Innovative Life Sciences Companies," a CPE-accredited conference for finance and accounting professionals across the life sciences spectrum, from pre-clinical startups to mature pharmaceutical companies.
The published themes: Accounting excellence, financial strategies for growth, digital transformation and AI integration, geopolitical and market dynamics, and industry insights and connections. Sessions run across Pre-Commercial, Commercial and Executive tracks plus interactive roundtables.
Two sessions stand out for their access: A SEC and FASB Town Hall brings a Professional Accounting Fellow from the SEC Office of the Chief Accountant together with a FASB Practice Fellow, and a Controllership Panel gathers chief accounting officers from Biogen, Vertex, Akebia and Roivant.
Part of Biotech Week Boston: The event is part of Biotech Week Boston but runs at the Sheraton Boston rather than the Hynes, and Informa Connect does not publish cross-access to the other co-located conferences.
Why Meet with DS2?
Clinical logistics is one of the harder lines to forecast. Kit builds, courier movements, storage and the integration work behind them often sit with several suppliers, which makes accruals and variance analysis more work than they need to be. DS2 runs the whole path, which means one partner, one set of documentation and one view of what a study is spending on getting samples where they need to be. What we do:
- Diagnostic and specimen collection kit design, assembly and fulfillment
- Kit-to-patient and direct-to-patient distribution
- Medical courier services, including STAT and next-flight-out specimen transport
- Cold chain and temperature-controlled logistics, with the documentation to prove the range held
- Biostorage and biorepository services
- Mobile phlebotomy and specimen collection
- LIS, LIMS and EMR integration, including HL7 and FHIR
- Chain of custody and compliance documentation
Consolidated kitting, distribution, courier, cold chain, biostorage and integration, priced and reported as one service. We're excited to talk through what that looks like on a programme budget in Boston.
Speaking Faculty
A selection from the 42 speakers published for 2026.
Adam S. Mostafa
Sitryx Therapeutics
Chief Financial Officer and Head of Business Development, conference chair
Sean Godbout
Biogen
Chief Accounting Officer and Global Controller
Jenni Humes
Roivant
Chief Accounting Officer
Richard Malabre
Akebia Therapeutics
Senior Vice President and Chief Accounting Officer
Maricel Apuli
BridgeBio
Chief Accounting Officer
Scott Godsoe
Vertex Pharmaceuticals
Executive Director, Assistant Corporate Controller
Justin Renz
Zevra Therapeutics
Chief Financial Officer
Kathleen Borthwick
Passage Bio
Chief Financial Officer
Kory Wentworth
Entrada Therapeutics
Chief Financial Officer
Melissa Bradford-Klug
NorthSea Therapeutics
Chief Financial and Business Officer
Nikita Mody-Patel
Moderna Therapeutics
Executive Director, FP&A
Richard Correa
Office of the Chief Accountant, U.S. Securities and Exchange Commission
Professional Accounting Fellow
Jennifer Deng
Financial Accounting Standards Board
Practice Fellow
The full speaker list is on the official speakers page.
The Agenda, Day by Day
Times below are as published by Informa Connect. The full agenda for both days is on the official agenda pages.
Day One · Thursday, September 24, 2026
Registration and networking breakfast
Chairperson's welcome and opening remarks
Adam S. Mostafa, Chief Financial Officer and Head of Business Development, Sitryx Therapeutics
Controllership panel: Driving Operational Excellence in a Transforming Landscape
Jen Cadigan, CrossCountry Consulting; Sean Godbout, Biogen; Scott Godsoe, Vertex Pharmaceuticals; Richard Malabre, Akebia Therapeutics; Jenni Humes, Roivant
Networking and refreshment break
SEC and FASB Town Hall
Wade Vigna, CFGI; Jennifer Deng, FASB; Richard Correa, Office of the Chief Accountant, U.S. Securities and Exchange Commission
Biotech Finance Outlook 2027: Pricing Pressures, Trade Risk and Global Market Dynamics
Jacqueline Green, Consulting Principal and Chief Economist, ITR Economics
Networking luncheon and solution summit
Erin Warner Guill, President and Chief Operating Officer, Auxilius
Pre-Commercial and Commercial tracks
Pre-commercial operational excellence with Passage Bio, Korsana Biosciences and Bicycle Therapeutics; operationalizing commercial finance
Pre-Commercial and Commercial tracks
Funding and operational readiness with QurAlis and Immuneering; revenue recognition and gross-to-net with Crowe, Sumitomo Pharma America, Alnylam and PharmaEssentia
Pre-Commercial and Commercial tracks
Financial readiness for commercialization with Wolf & Company, Elicio Therapeutics and EyePoint; global launch excellence
Executive Think Tank and interactive roundtables
Meagan Caldwell, Sumitomo Pharma America; Soufiane Younoussi, BPGbio; Pete Paras, Biogen
Close of day one and evening networking reception
Day Two · Friday, September 25, 2026
Networking breakfast
Chair's day one recap
Adam S. Mostafa, Sitryx Therapeutics
Optimizing ERP Systems: Tools and Strategies for Biotech Growth
Kyle Mandala and Maggie Berkeley, RSM US; Michelene Taptich, Priovant Therapeutics; Gina Tracey, Alnylam Pharmaceuticals
Biotech Financing Insights: Navigating Dynamic Capital Markets
Ethan Holdaway, ProKidney; Bill Steinkrauss, ILiAD Biotechnologies; Neeraj Kumar, Novartis
Portfolio Prioritization and Capital Strategy
Mallory Morales, Senior Vice President Finance and Chief Accounting Officer, Immuneering Corporation
Networking and refreshment break
CFO panel: Redefining Financial Leadership for Organizational Success
Kristen Godsoe, Baker Tilly; Justin Renz, Zevra Therapeutics; Kathleen Borthwick, Passage Bio; Kory Wentworth, Entrada Therapeutics; Mark Mullikin, Ensem Therapeutics
Networking luncheon
Navigating Clinical Trials Finance: Accruals, Automation and AI Integration
Jennifer Kyle, Founder and Chief Executive Officer, Condor Software
AI in Action: Practical Use Cases Transforming Biotech Finance Operations
Soufiane Younoussi, BPGbio; Jessica Marenco, Roivant Sciences
Mastering Capital Allocation: Strategies for Successful Commercialization and Product Launches
Melissa Bradford-Klug, NorthSea Therapeutics; Nikita Mody-Patel, Moderna Therapeutics
Chair's closing remarks and close of conference
Adam S. Mostafa, Sitryx Therapeutics
Useful Finance & Accounting for Bioscience Resources
The official event page.
AgendaDay one, with day two linked from it.
SpeakersThe published faculty.
PricingRegistrant types and rates.
CPE CreditsAccreditation detail.
Plan Your VisitVenue, hotel and travel.
Book Your HotelThe Sheraton Boston room block.
Conference AppThe ConnectMe attendee app.
Book NowRegistration.
Finance & Accounting for Bioscience 2026 FAQ
General
Registration & travel
See You in Boston
Boston, September 24 and 25. Send over where your clinical logistics spend currently sits and we'll set aside time to talk about consolidating it.